Digital weight loss company Noom announced its commercial business, Noom for Work, is partnering with Liviniti, a national pharmacy benefit manager, to offer plan sponsors and their employees a digital GLP-1 Companion for chronic weight conditions.
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used in the treatment of type 2 diabetes and, more recently, in the...
